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Abstract
Progression through the cell cycle involves the coordinated activities of a suite of cyclin/cyclin-dependent kinase (CDK)
complexes. The activities of the complexes are regulated by CDK inhibitors (CDKIs). Apart from its role as cell cycle
regulators, CDKIs are involved in apoptosis, transcriptional regulation, cell fate determination, cell migration and
cytoskeletal dynamics. As the complexes perform crucial and diverse functions, these are important drug targets for tumour
and stem cell therapeutic interventions. However, CDKIs are represented by proteins with considerable sequence
heterogeneity and may fail to be identified by simple similarity search methods. In this work we have evaluated and
developed machine learning methods for identification of CDKIs. We used different compositional features and evolutionary
information in the form of PSSMs, from CDKIs and non-CDKIs for generating SVM and ANN classifiers. In the first stage, both
the ANN and SVM models were evaluated using Leave-One-Out Cross-Validation and in the second stage these were tested
on independent data sets. The PSSM-based SVM model emerged as the best classifier in both the stages and is publicly
available through a user-friendly web interface at http://bioinfo.icgeb.res.in/cdkipred.
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Introduction
Cyclin-dependent kinases (CDKs) are poised to play a central
role in the orderly transition of the eukaryotic cells through
different stages of the mitotic cell division cycle [1]. The activities
of the CDKs are controlled by a tight network of regulatory
mechanisms, which comprise activatory/inhibitory phosphoryla-
tion and dephosphorylation events [2], controlled degradation of
the cyclin partner and association with effectors (CDK inhibitors
or CDKIs) [1,3]. Several CDKIs (such as p21, p57, p27 etc.)
function as tumour supressors [4,5,6,7] and loss/subversion of its
activities (by mutations, elevated or decreased levels of expression
etc.) results in the development of tumours, cancers and neoplasms
[8,9]. The importance of CDKIs in benign and malignant
leukaemias, urological and other diseases (e.g. p57 in Beckwith-
Wiedemann Syndrome) [10] is a subject of intense ongoing
investigation. Though initially considered as tumour suppressors
based on their ability to block cell proliferation, CDKIs play
pertinent roles in the regulation of a myriad of cellular processes
including transcription, apoptosis, cell migration and cytoskeletal
dynamics, which may be oncogenic under certain circumstances
[3,11]. Due to the involvement of CDKs in critical cellular roles,
inhibition of CDKs harbors immense relevance for anticancer
therapy [11]. Inhibition of CDKs could be accomplished both by
over expression of cellular CDKIs [12] as well as pharmacological
inhibitors. Cellular CDKIs e.g. the tumour suppressor gene
products p16
INK4, p21
WAF1, and p27
KIP1, form the starting point
for the design of mechanism-based CDK inhibitors [13]. Analysis
of the structural aspects of cellular CDKIs leads to the
identification of inhibitory lead peptides amenable to peptidomi-
metic development. Conversion of these peptides into pharma-
ceutically useful molecules provides a wealth of potential drug
candidates capable of inhibiting CDKs, blocking cell-cycle
progression, modulating transcription and inducing apoptosis
selectively in cancer cells. Some of these, such as flavopiridol
(L868275, HMR1275; Aventis), 7-hydroxystaurosporine (UCN-
01, KW-2401; Kyowa Hakko Kogyo) and roscovitine (R-
roscovitine, CYC202; Cyclacel), have already reached the stage
of clinical evaluation [14,15]. These pharmacological CDKIs
herald the opening of new avenues of clinical therapies against
such intractable pathogens like human immunodeficiency virus
(HIV-1) [16] and several protozoan parasites like Plasmodium,
Trypanosoma and Leishmania [17,18,19]. CDKIs also constitute
potential targets for therapeutic stem cell manipulations [20].
In the light of well established significance of CDKI proteins
within the cell and in the development of pharmacological CDK
inhibitors, it becomes essential to have facile methods of
identifying these proteins. However, these exhibit a lot of diversity
in their amino acid sequences. These are represented by INK4
[21] and Cip/Kip [22] families in mammals, Sic1 protein [23] in
fungi and SIAMESE (SIM) [24] family and ICK/KRP (Inhibitor
of CDK/Kip-Related Protein) [25] family in plants. Owing to this
enormous diversity, its identification is precluded by simple
similarity-based approaches. As an alternative to similarity based
methods, we applied two machine learning techniques, namely,
Support Vector Machines (SVM) and Artificial Neural Networks
(ANN) to address this problem. We used compositional features
including amino acid composition (AAC), Split Amino Acid
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dipeptide composition (2-gram), as well as evolutionary informa-
tion from the Position-Specific Scoring Matrix (PSSM) profiles
obtained from Position-Specific Iterative-Basic Local Alignment
Search Tool (PSI-BLAST) for training the classifiers.
Given the immense biomedical merit and therapeutic potential
of CDKIs, we anticipate that this would be a useful tool for the
research community.
Results
Performance of alignment-based techniques
The positive training set was checked for the presence of Pfam
[26] domains. The Pfam database contains three CDKI-related
profiles (CDI (PF02234), CDKN3 (PF05706) and P19Arf_N
(PF07392)). It was found that only 40 out of 56 CDKI sequences
showed the presence of any one of these three Pfam signatures at
an E-value threshold of 1.0. Moreover, the high diversity in the
sequences of CDKIs would preclude the detection of the true
positives also with similarity-based searches. This was evident from
our assessment of PSI-BLAST on the positive dataset in a manner
similar to Leave-one-out cross-validation (LOO CV).
Three iterations of PSI-BLAST were carried out at an E-value
threshold of 0.001. Each sequence was used as the query sequence
once while the rest were used as the reference database and this
was looped over each sequence. It was found that 10 sequences did
not find any significant hit, bringing forth that general methods of
similarity-based searches do not provide a reliable solution to the
identification of CDKIs and a method specific to these proteins
should be developed. Therefore, we set forth to explore machine-
learning based methods based on various protein features for the
prediction of CDKI proteins.
Performance of alignment-free methods - SVM and ANN
SVM. Several SVM models were generated by varying the
parameters C and c during LOO CV, however only the best ones
(as described in Methods) were selected and are depicted in
Table 1. The performance measures were checked at different
thresholds of SVM scores ranging from 21.0 to 1.0 and the
threshold where the model yielded the best ones was used for
further predictions by the model. The PSSM based model showed
the best accuracy (90.44%), followed by AAC (89.88%), DPC
(86.23%), SAAC (83.42%) and 2-gram composition (79.77%). The
other measures (sensitivity, specificity, Matthews Correlation
Coefficient (MCC), Positive predictive value (PPV) etc.) also
followed the same order. Thus PSSM model emerged as the best
one amongst the SVM classifiers. Moreover, the performance of
the PSSM model was an improvement over the normal PSI-
BLAST search (as described in the previous section), since here the
sensitivity was 49/56 (87.50%) unlike PSI-BLAST (where it was
46/56, i.e. 82.14%). PSSM-based SVM classifiers are have been
employed for a plethora of classification problems in biology and
are well known for their remarkable performance for extremely
diverse proteins like lipocalins [27], nucleic acid binding proteins
[28], etc. Apart from capturing residue composition, the PSSM
profiles encapsulate useful information about conservation of
residues at crucial positions within the protein sequence, because
in evolution the amino acid residues with similar physico-chemical
properties tend to be highly conserved due to selective pressure.
Neural networks. Different ANNs were generated for the
different types of features, while optimizing the learning
parameters including activation function, number of hidden
neurons, learning rate etc. The approach was to keep the
number of hidden neurons and the number of training cycles as
low as possible while simultaneously achieving good accuracies in
cross-validation. Each of the neural networks had a multilayer feed
forward topology. The vanilla backpropagation [29] algorithm
was used to minimize the differences between the computed
output and the target value. Random weights were used for
initializing the net. The best ones for each feature are described
below and tabulated in Table 2.
AAC based ANN. This consisted of a fully-connected
network, with 20 nodes in the input layer, 12 in the hidden
layer and 1 in the output layer. The linear activation function was
used for the input layer while the logistic function was used for the
hidden and the output layer. The training was carried out for 5000
cycles and learning terminated when SSE was minimum. This
yielded an accuracy of 85.11%, but sensitivity was lower (67.85%)
than specificity (88.33%).
SAAC based ANN. This consisted of a fully-connected
network, with 60 nodes in the input layer, 8 in the hidden layer
and 1 in the output layer. In this case too the linear activation was
used for the input layer with the logistic function for the other two
layers. The training was carried out for 1000 cycles and learning
terminated when SSE was minimum. This had an accuracy of
85.11%, but sensitivity (64.28%) was even lower than the AAC-
based ANN, while specificity was a little higher than the latter
(89%).
DPC based ANN. This consisted of a fully-connected
network, with 400 nodes in the input layer, 2 in the hidden
layer and 1 in the output layer. Here, the logistic function was used
as activation function for each of the three layers. The training was
carried out for 2000 cycles and learning terminated when SSE was
minimum. This had an accuracy of 90.44%, and appreciably
higher sensitivity (82.14%) than other ANNs with a high specificity
of 92%.
2-gram based ANN. This consisted of a fully-connected
network, with 400 nodes in the input layer, 2 in the hidden layer
Table 1. Performance of different SVM classifiers in LOO CV.
Model C c Th SN (%) SP (%) Accuracy (%) MCC PPV
AAC 1 0.01 20.7 87.50 90.33 89.88 0.68 0.62
SAAC 5 0.001 20.6 83.92 83.33 83.42 0.55 0.48
DPC 0 0.01 20.7 85.71 86.33 86.23 0.60 0.53
2-gram 0 0.01 20.8 82.14 79.33 79.77 0.48 0.42
PSSM 5 5.00 20.6 87.50 91.00 90.44 0.69 0.64
Th- Threshold, SN – sensitivity, SP – specificity, MCC – Matthews Correlation
Coefficient, PPV- Positive predictive value.
doi:10.1371/journal.pone.0013357.t001
Table 2. Performance of best ANN classifiers in LOO CV.
Model SN (%) SP(%) Accuracy (%) MCC PPV
AAC 67.85 88.33 85.11 0.50 0.27
SAAC 64.28 89.00 85.11 0.49 0.52
DPC 82.14 92.00 90.44 0.67 0.65
2-gram 69.64 89.66 86.51 0.54 0.27
PSSM 67.85 91.66 87.92 0.56 0.60
SN – sensitivity, SP – specificity, MCC – Matthews Correlation Coefficient, PPV-
Positive predictive value.
doi:10.1371/journal.pone.0013357.t002
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activation function for all the three layers and the training was
carried out for 1000 cycles. This ANN had a higher sensitivity
(69.64%) than AAC- and SAAC- based ANNs but could not
provide any improvement over the DPC-based ANN. The overall
accuracy was 86.51% and specificity was 89.66%.
PSSM-based ANN. This consisted of a fully-connected
network, with 400 nodes in the input layer, 10 in the hidden
layer and 1 in the output layer. The logistic activation was used for
input and output layers while linear activation function was
employed for hidden layer. The training was carried out for 6500
cycles and terminated at minimal SSE. This ANN had overall
accuracy of 87.92% and specificity of 91.66% with low sensitivity
of 67.85% and could not provide any significant improvement
over other ANNs.
Though the overall accuracy was good enough with all the
ANNs, it had a higher contribution from the negative set rather
than the positive set, so the DPC-based ANN emerged as the most
efficient classifier which had good sensitivity as well as specificity.
Performance on benchmark datasets
We tested the performance of the best classifiers only on the
benchmark datasets (i.e. Datasets S3 and S4). Table 3 depicts the
sensitivity, specificity and PPV of these classifiers on these two
datasets. Herein, we observed better prediction efficiency for the
DPC-based SVM model over the AAC-based SVM model, unlike
that in cross-validation. It is plausible that some over-fitting of data
could have occurred in cross-validation with AAC. The DPC-
based ANN also performed almost at par with the SVM models.
As expected, the PSSM-based SVM model yielded the best
performance amongst all the tested classifiers on all the test sets.
Based on the performance in LOO CV and on benchmark
datasets, the PSSM-based SVM model was selected as the best
model. Its performance was further tested on randomly picked up
phosphatases and kinases (Datasets S5 and S6). A number of
phosphatases and kinases bind to CDKs as do the CDKIs.
Moreover a CDK inhibitor i.e. Cyclin-dependent kinase inhibitor
3 (CDKN3) or Kinase-associated phosphatase (KAP), is a dual-
specificity phosphatase which contains the HCXX-XXGR motif
characteristic of protein tyrosine phosphatases [30]. This protein
binds to CDK2 and dephosphorylates Thr160 when the associated
cyclin subunit is degraded or dissociates, thereby rendering CDK2
inactive [31,32]. Hence phosphatases and kinases are potent
candidates for false positive predictions.
Amongst the 65 kinases, two were wrongly predicted as CDKIs
while amongst the 65 phosphatases, four were wrongly predicted
as CDKIs by the PSSM-based SVM model. Thus the false positive
prediction rate of the model is low enough to justify its utility for
practical applications.
Receiver Operating Characteristic (ROC) plot
ROC curves show the trade-off between true positive rate
(sensitivity) and false positive rate (1- specificity) over their entire
range of possible values. It is considered as the most robust
approach for classifier evaluation [33]. The Area Under Curve
(AUC) is used as a reliable index of classifier performance. This
validates the threshold-independent performance of the classifiers.
We plotted the ROC curve for the best classifier, PSSM-based
SVM model (Figure 1). The curve had an AUC of 0.933 which
further reinforced the discriminative efficiency of the model.
Web implementation
The Web server was developed using Apache (version 2.0).
Server side scripting was done in PHP (version 5.0). The
prediction algorithm presented in this study is implemented as a
freely accessible web server at http://bioinfo.icgeb.res.in/cdkipred
(Figure 2). The program predicts CDKI sequences using the SVM
model based on PSSM profile. The input sequences are provided
in the FASTA format. The program allows the users to perform
prediction at thresholds ranging from 21.0 to 1.0 for SVM score.
The program output returns the sequence ID, the SVM score and
the decision of the classifier regarding the sequence based on the
threshold chosen.
Discussion
This is the first report of a machine-learning-based method for
identification of CDKI protein sequences. Previously, such
approaches have been applied to the computational identification
of other components of the cell cycle including cyclins [34] and
CDK phosphorylation substrates [35].
Our tool simply represents a complementary tool to allow the
detection of CDK inhibitors, since we prove that PFAM signatures
miss a significant number of the already known CDK inhibitors
Table 3. Performance on benchmark datasets.
Model Positive set (48) Negative set (308) PPV
SVM-AAC 38 (79.16) 274 (88.96) 0.52
SVM-DPC 45 (93.75) 285 (92.53) 0.66
SVM-PSSM 47 (97.91) 294 (95.45) 0.77
ANN-DPC 42 (87.50) 277 (89.93) 0.57
PPV- Positive Predictive Value. The numbers show the correctly predicted
sequences out of the total shown in the first row, 48 for the positive set and 308
for the negative set. The sensitivity and specificity percentages are reported
within the brackets in the second and third columns respectively.
doi:10.1371/journal.pone.0013357.t003
Figure 1. ROC plot of PSSM-based SVM model. The ROC curve
depicts relative trade-offs between true positive and false positives. The
green line is the reference line while the blue curve represents the ROC
curve for the PSSM-based SVM model with an Area Under Curve (AUC)
of 0.933.
doi:10.1371/journal.pone.0013357.g001
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based methods do come at the cost of some false positive
predictions, which should be as minimal as possible. We tested this
on an independent dataset comprising of randomly picked up non-
CDKIs as well as kinases and phosphatases which are the most
likely candidates for false positive predictions and indeed obtained
a low false positive prediction rate.
In this study, we observed that SVM based methods are more
efficient than ANN in discrimination of CDKI and non-CDKI
sequences, despite the imbalance in the size of the positive and the
negative training datasets (56 and 300 respectively). This was
observed with all the types of features (Table 1 and Table 2). For
an experimenter, a judicious approach would be minimizing the
number of CDKIs to be characterized by increasing the threshold
to higher SVM score, in order to get only the topmost candidates
for further work. Supplementing these with other complementary
evidence like domain knowledge and sub-cellular localization may
provide inroads to the discovery of novel CDKIs and further our
understanding of cell cycle regulation and other cellular
phenomena. In future, the availability of more sequences and
inclusion of more features may further enhance the prediction
accuracy.
Methods
Generation of datasets for SVM and ANN training
Two sets containing CDKI and non-CDKI sequences were
compiled from different databases- including Genbank, SwissProt
and RefSeq. The positive set was prepared through keyword
search using keywords like ‘CDK inhibitor’ while the negative set
was assembled by randomly picking the non-CDKIs. Both the sets
were manually inspected to prevent the mislabeling of the data.
The redundancy in both the sets was removed at a similarity
threshold of 40% using the CD-HIT program [36]. This yielded a
positive set of 56 well-annotated and mostly experimentally
verified CDKIs (Dataset S1) and a negative set of 300 non-
CDKIs (Dataset S2).
Benchmark dataset for testing
In order to gauge the utility of our best SVM models and ANNs
for unseen sequences, we tested their performance on independent
datasets not used in training or testing cycles. While one test
dataset consisted of 48 CDKIs (Dataset S3), the other had 308
non-CDKIs (Dataset S4). Moreover, we prepared two datasets for
testing the performance of the best model in the study. These
consisted of randomly picked up sequences of 65 phosphatases
(Dataset S5) and 65 kinases (Dataset S6) from SwissProt.
Training features used as input for SVMs and NNs
Different compositional features, i.e. AAC, SAAC, DPC and 2-
gram composition were extracted from the positive and negative
dataset sequences. Evolutionary information in the form of PSSM
profiles for both the sets was also used to train SVM models and
ANNs.
AAC is the fraction of each of the 20 amino acids present in a
protein sequence. This generates an input vector of 20 dimensions.
For calculating SAAC, the protein was split into three parts of
equal length and the fraction of each amino acid calculated
separately for the three. This generates an input vector of 60
dimensions. DPC is the fraction of a dipeptide divided by the total
number of possible dipeptides in the given protein sequence. This
yields a training vector of 400 dimensions. 2-gram composition is
the fraction of dipeptides composed by two amino acids with one
separating residue in between. This yields a training vector of 400
dimensions. The PSSM was obtained by performing PSI-BLAST
against SwissProt database (release 57.13) at the E-value threshold
Figure 2. Snapshot of web server sample output. The web server predicts CDKIs based on the best classifier, i.e. PSSM-based SVM model. The
server accepts FASTA formatted sequences and allows user defined thresholds of prediction, ranging from 21.0 to 1.0.
doi:10.1371/journal.pone.0013357.g002
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elements, N being the length of the query sequence, and each
element represents the frequency of a particular residue substitu-
tion at a specific position in the alignment. To generate input
vectors of fixed length for SVM training, the PSSM matrix was
normalized between 0 and 1 using the following logistic function:
g(x)~
1
1zexp({x)
Where x is the raw value in PSSM profile and g(x) is the
normalized value of x. Following this, the normalized matrix is
organized into a composition matrix of fixed length pattern of 400
(20620, for each amino acid, there are 20 substitution scores from
normalized matrix).
SVMs and SVM
light
SVM is a supervised machine learning method extensively used
in classification and regression problems based on Structural Risk
Minimization (SRM) principle from statistical learning theory
[37]. SVM is used in conjunction with kernel functions which
implicitly map input data to a higher dimensional non-linear
feature space. SVM builds a model (classifier) by constructing an
optimal hyperplane that divides the positively and negatively
labeled samples with the maximum margin of separation. To
construct an optimal hyperplane, SVMs employ an iterative
training algorithm, which is used to minimize an error function.
Hyperplanes are searched in the space of possible inputs;
subsequently these hyperplanes are used to separate positive and
negative patterns. The selected data points supporting the
hyperplane are called support vectors.
We implemented SVM using the software SVM
light written and
distributed by Joachims [38]. This package enables users to select
from a choice of inbuilt kernel functions and to define a number of
parameters for each kernel function. For a given kernel function, a
large number of models (classifiers) can be built by varying the
input values for its parameters and evaluated. We used Radial
Basis Function (RBF) kernel to train and test our training datasets.
The values of c and regularization parameter C were optimized on
the training datasets by cross-validation. The approach was aimed
at choosing the parameters so as to maximize accuracy along with
nearly equal sensitivity and specificity, wherever possible.
ANN and SNNS
The Artificial Neural Network (ANN) consists of nodes or
neurons that receive signals through interconnecting arcs [39].
Signals are passed between neurons (organized in input, hidden
and output layers) through connection links which carry an
associated weight. Each neuron applies a non-linear transforma-
tion called an activation function to its net input to determine it
output signal.
We used the freely available package Stuttgart Neural Network
Simulator (http://www.ra.cs.uni-tuebingen.de/SNNS/), SNNS
version 4.2 to implement ANN. One advantage that this package
offers is that it allows the incorporation of the trained networks in
ANSI C functions for use in stand-alone code. The feed-forward
back propagation type of neural networks was trained on different
protein features. The number of hidden nodes and other learning
parameters were optimized for each network. The output unit
consisted of target value 1 or 0, referring to positives and negatives
respectively. The Sum of Squared Error function (SSE) on training
was monitored after every training cycle. The final number of
cycles was determined where the SSE was the least. The value of
the learning rate was set to 0.1.
Leave-One-Out Cross -Validation (LOO CV)
This is considered as the most objective and rigorous mode of
evaluation wherein one dataset sequence is kept for testing, while
the rest are used to train the model/NN. This is repeated till each
sequence becomes the testing data exactly once. This is a stringent
case of n-fold cross-validation where n equals the total number of
sequences. The various performance measures (explained below)
are taken for n folds and then averaged to get overall assessment of
the classifier.
Classifier performance metrics
To evaluate the accuracy of SVM classifiers and ANNs
developed in cross-validation cycles; we used four measures.
Sensitivity is defined as the percentage of CDKI protein sequences
that are correctly predicted as CDKIs. Specificity is the percentage
of non-CDKI protein sequences that are correctly predicted as
non-CDKIs. Accuracy is the percentage of correct predictions out of
total number of predictions. Matthews correlation coefficient (MCC) is a
measure of both sensitivity and specificity, MCC=0 indicates
completely random prediction, while MCC=1 indicates perfect
prediction. Positive predictive value (PPV) is the likelihood that a
sequence reported by the classifier as CDKI is really CDKI.
Sensitivity~
TP
TPzFN
|100
Specificity~
TN
TNzFP
|100
Accuracy~
TPzTN
TPzFPzTNzFN
|100
MCC~
(TP|TN){(FN|FP)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(TPzFN)|(TNzFP)|(TPzFP)|(TNzFN)
p
PPV~
TP
TPzFP
Receiver Operating Characteristic (ROC) plot
Statistical Package for Social Sciences (SPSS v16.0) for
Windows was used to obtain the ROC plot [40] for the best
classifier obtained in the study.
Supporting Information
Dataset S1 Set of 56 annotated and mostly experimentally
verified CDKIs.
Found at: doi:10.1371/journal.pone.0013357.s001 (0.02 MB
TXT)
Dataset S2 Set of 300 non-CDKI sequences.
Found at: doi:10.1371/journal.pone.0013357.s002 (0.20 MB
TXT)
Dataset S3 Sequences of 48 CDKI sequences not used in the
training/testing.
Found at: doi:10.1371/journal.pone.0013357.s003 (0.01 MB
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Dataset S4 Sequences of 308 non CDKI sequences not used in
the training/testing.
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Dataset S5 Phosphatase sequences used for evaluation of false
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Dataset S6 Kinase sequences used for evaluation of false
positives.
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